- Home
- OBIO vs MRAM Comparison
OBIO vs MRAM Comparison
Compare OBIO & MRAM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OBIO
- MRAM
- Stock Information
- Founded
- OBIO 2017
- MRAM 2008
- Country
- OBIO United States
- MRAM United States
- Employees
- OBIO N/A
- MRAM N/A
- Industry
- OBIO Medicinal Chemicals and Botanical Products
- MRAM Semiconductors
- Sector
- OBIO Health Care
- MRAM Technology
- Exchange
- OBIO Nasdaq
- MRAM Nasdaq
- Market Cap
- OBIO 172.1M
- MRAM 150.5M
- IPO Year
- OBIO N/A
- MRAM 2016
- Fundamental
- Price
- OBIO $4.24
- MRAM $8.03
- Analyst Decision
- OBIO Strong Buy
- MRAM Strong Buy
- Analyst Count
- OBIO 4
- MRAM 1
- Target Price
- OBIO $13.67
- MRAM $10.50
- AVG Volume (30 Days)
- OBIO 301.5K
- MRAM 249.9K
- Earning Date
- OBIO 11-10-2025
- MRAM 11-05-2025
- Dividend Yield
- OBIO N/A
- MRAM N/A
- EPS Growth
- OBIO N/A
- MRAM N/A
- EPS
- OBIO N/A
- MRAM N/A
- Revenue
- OBIO $2,818,000.00
- MRAM $53,642,000.00
- Revenue This Year
- OBIO $31.43
- MRAM $10.80
- Revenue Next Year
- OBIO $10.87
- MRAM $13.42
- P/E Ratio
- OBIO N/A
- MRAM N/A
- Revenue Growth
- OBIO 6.46
- MRAM N/A
- 52 Week Low
- OBIO $2.20
- MRAM $4.34
- 52 Week High
- OBIO $6.30
- MRAM $12.27
- Technical
- Relative Strength Index (RSI)
- OBIO 63.87
- MRAM 38.77
- Support Level
- OBIO $3.86
- MRAM $7.96
- Resistance Level
- OBIO $4.02
- MRAM $9.77
- Average True Range (ATR)
- OBIO 0.30
- MRAM 0.52
- MACD
- OBIO 0.00
- MRAM -0.24
- Stochastic Oscillator
- OBIO 89.22
- MRAM 7.96
About OBIO Orchestra BioMed Holdings Inc.
Orchestra BioMed Holdings Inc is a biomedical innovation company accelerating high-impact technologies to patients through risk-reward sharing partnerships. Its partnership-enabled business model focuses on forging strategic collaborations with medical device companies to drive the commercialization of the products it develops. The company's flagship product candidates include BackBeat Cardiac Neuromodulation Therapy (CNT) for the treatment of hypertension and Virtue Sirolimus AngioInfusionBalloon (SAB) for the treatment of atherosclerotic artery disease.
About MRAM Everspin Technologies Inc.
Everspin Technologies Inc is a provider of Magnetoresistive Random Access Memory (MRAM) products. Its portfolio of MRAM technologies, including Toggle MRAM and Spin-transfer Torque MRAM (STT-MRAM), delivers superior performance, persistence, and reliability in non-volatile memories that transform how mission-critical data is protected against power loss. The company derives revenue from the sale of MRAM-based products in discrete unit form, licenses of and royalties on MRAM and magnetic sensor technology, the sale of backend foundry services, and design services to third parties. It recognizes revenue in three primary geographic regions; North America; Europe, the Middle East, and Africa (EMEA) and Asia-Pacific (APAC).